abstract |
The present invention relates to oncolytic adenoviral vectors and chemotherapeutic agents. More specifically, the present invention relates to oncolytic adenoviral vectors and chemotherapeutic agents for use in cancer treatment. The combination treatments described herein have excellent safety properties and effective therapeutic activity. |